Afya Limited Stock Price, News & Analysis

Afya (Nasdaq: AFYA) announced that Afya Participações S.A. approved a private placement of book-entry commercial notes totaling R$1,500.0 million in two series to be sold to Opea and securitized via a debenture.

The issuance is intended for October 15, 2025; the First Series is R$500.0 million maturing Oct 15, 2028 and the Second Series is R$1,000.0 million maturing Oct 15, 2030. Interest equals the Brazilian daily interbank deposit rate (DI) plus spreads of 0.70% (First Series) and 0.85% (Second Series) per year. Notes will be guaranteed by three subsidiaries. Proceeds are for general corporate purposes, including optional early debenture redemption and repurchase of perpetual convertible preferred shares.

Afya Limited (Nasdaq: AFYA), Brazil's leading medical education group, reported strong Q2 2025 financial results with revenue increasing 13.5% YoY to R$919.4 million. The company achieved significant margin expansion with Adjusted EBITDA growing 16.6% YoY to R$400.8 million and margin reaching 43.6%.

Key highlights include net income growth of 8.8% YoY to R$176.5 million, strong operating cash conversion of 88.8%, and a robust ecosystem reaching ~302,000 users. The company completed the acquisition of FUNIC for R$100 million, adding 60 medical seats, and announced a new share repurchase program for up to 4 million Class A shares. Management reaffirmed full-year 2025 guidance with expected revenue between R$3,670-3,770 million.

Afya (NASDAQ: AFYA), Brazil's leading medical education group, has announced a new share repurchase program approved by its Board of Directors. The company plans to repurchase up to 4,000,000 Class A common shares through open market or private transactions.

The program will run from August 15, 2025 to December 31, 2026. The repurchased shares will be used for Afya's stock option program, future business combinations, and general corporate purposes. The company will fund the buyback using existing funds and future dividends from Afya Participações, with purchases intended to comply with SEC Rule 10b-18 safe harbor provisions.

Afya Limited (NASDAQ: AFYA), Brazil's leading medical education and practice solutions provider, has published its 2024 Sustainability Report. The comprehensive report adheres to multiple international reporting frameworks including GRI standards, SASB indicators, and aligns with the Sustainable Development Goals (SDGs).

The report features the company's fifth Greenhouse Gas Emissions Inventory and comprises two parts: a narrative document and a technical Excel annex. Both components have been independently audited by KPMG.

Afya Limited (Nasdaq: AFYA), a Brazilian education company, announced the successful completion of its Annual General Meeting on June 24, 2025. The shareholders approved all resolutions presented, including the ratification of the company's 2024 financial statements and the re-appointment of four independent directors.

The re-appointed directors, each serving a two-year term, are João Paulo Seibel de Faria, Vanessa Claro Lopes, Miguel Filisbino Pereira de Paula, and Marcelo Ken Suhara.

Afya Limited (AFYA) has announced its Annual General Meeting (AGM) scheduled for June 24, 2025, at 10:00 a.m. BRT, to be held both physically in Nova Lima, Brazil, and virtually. The meeting agenda includes approval of 2024 financial statements and re-appointment of four independent directors: João Paulo Seibel de Faria, Vanessa Claro Lopes, Miguel Filisbino Pereira de Paula, and Marcelo Ken Suhara, each for two-year terms. The record date is set for May 14, 2025. Shareholders can participate virtually via a secure link and are encouraged to vote either in person or by proxy. The Board recommends shareholders vote "FOR" all resolutions.

Afya Limited (NASDAQ: AFYA), Brazil's leading medical education and practice solutions provider, has announced a change in its independent auditing firm. The company's board of directors, following the audit committee's recommendation, has approved KPMG Auditores Independentes Ltda. to replace Ernst & Young Auditores Independentes S/S Ltda. as its independent registered public accounting firm. KPMG will begin its auditing services with the review of Afya's quarterly information for Q2 2025.

Afya Limited (NASDAQ: AFYA) reported strong Q1 2025 financial results with significant growth across key metrics. Net Revenue increased 16.4% YoY to R$936.4 million, while Adjusted EBITDA grew 23.7% YoY to R$492.0 million with a margin expansion of 300 bps to 52.5%. Net Income rose 23.4% YoY to R$257.0 million. The company maintained high occupancy rates in medical schools and successfully integrated recent acquisitions, including Unidom. Afya's ecosystem reached over 317,000 users, and the company received an upgraded credit rating to AAA.br from Moody's. The acquisition of Funic added 60 medical seats, bringing total approved seats to 3,653. The company reaffirmed its 2025 guidance, projecting net revenue between R$3,670-3,770 million and Adjusted EBITDA of R$1,620-1,720 million.

Afya Limited (NASDAQ: AFYA) has completed the acquisition of FACULDADE ÚNICA DE CONTAGEM (FUNIC) for R$100 million. The acquisition adds 60 medical school seats to Afya's portfolio, with operations expected to begin in H2 2025. The payment structure includes R$60 million paid in cash and R$40 million to be paid in three annual CDI-adjusted installments. A contingent consideration provides for an additional payment of R$1 million per seat for up to 60 additional medical school seats if approved by MEC within 36 months. The pre-operational facility is located in Contagem, near Belo Horizonte, Minas Gerais. At full maturity in 2030, Afya projects an EV/EBITDA of 3.3x post-synergies, with expected Net Revenues of R$52.4 million entirely from medical education.